FEBRUARY 19, 2012

Beyond the Abstract - Sorafenib and Surgical Complications: A Case Report of Adverse Reaction to Sorafenib during Treatment for Renal Cell Carcinoma

E-mail Print

BERKELEY, CA (UroToday.com) - In order to validate our observation that Sorafenib was the cause of the gross changes seen in the ileostomy, full thickness biopsies of the ileostomy were taken shortly after Sorafenib was discontinued.




Your session will expire in 8 hours requiring you to log in each day to view content.
Share |